WI-23-0001
This amendment adds enhanced mobile crisis services to the Medicaid state plan.
MO-22-0025
This Medicaid State Plan Amendment (SPA) provides for the transformation of MO HealthNet nursing facility reimbursement rates by establishing a new reimbursement methodology.
PR-23-0011
Establishes compliance with the mandatory coverage and reimbursement of routine patient costs furnished concerning participation in qualifying clinical trials under Section 1905(gg) of the Social Security Act.
MS-23-0004
State Plan Amendment (SPA) 23-0004 was submitted to add reimbursement for emergency ambulances for the initial twenty-five (25) miles at a rate of $.01 per mile, effective February 1, 2023.
UT-23-0028
Through this SPA, the state updates the CHIP out of pocket maximum member notification process. The state will use a new Provider Reimbursement Information System (PRISM) process that will track, calculate and inform members of when the 5 percent out of pocket maximum cost has been met.
IA-23-0008
This SPA demonstrates compliance with requirements in the American Rescue Plan Act of 2021 (ARP) that 1) mandate coverage of COVID-19 testing, treatment, and vaccines and their administration without cost-sharing or amount, duration, or scope limitations; and 2) require states to cover, without cost sharing, the treatment of conditions that may seriously complicate COVID- 19 treatment, during the period when a beneficiary is diagnosed with or is presumed to have COVID-19.
ME-23-0006-ME-23-0007
These SPAs allow Maine to transition its separate CHIP program, CubCare, to a Medicaid expansion program effective March 1, 2023, with the exception of the from-conception-to-end of-pregnancy population (otherwise known as the “unborn option”).
WI-23-0010
This SPA extends the state’s authority to implement certain cost sharing flexibilities after the end of the federally declared PHE through the unwinding period.
AR-23-0006
This SPA demonstrates compliance with requirements in the American Rescue Plan Act of 2021 (ARP) that 1) mandate coverage of COVID-19 testing, treatment, and vaccines and their administration without cost-sharing or amount, duration, or scope limitations; and 2) require states to cover, without cost sharing, the treatment of conditions that may seriously complicate COVID- 19 treatment, during the period when a beneficiary is diagnosed with or is presumed to have COVID-19.